NCI series of cell lines: An historical perspective

Journal of Cellular Biochemistry

Volumn 62, Issue 3324, 1996, Pages 1-11

  Gazdar, Adi F ^a,b   Minna, John D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cell culture; HIV; Human; Lung carcinoma; Retroviruses

Indexed keywords

EID: 33646962490     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630502     Document Type: Article

References (75)

1. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG (1980): Mitogen requirements for the propagation of cutaneous T-cell lymphomas. Blood 55:409-417.
2. Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PJ, Guccion JG, Minna JD (1980): Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res 40:35-2-7.
3. Oboshi S, Tsugawa S, Seido T, Shimosato Y, Koide T (1971): A new floating cell line derived from human pulmonary carcinoma of oat cell type. Gann 62:505-14.
4. Pettengill OS, Faulkner CS, Wurster HD, Maurer LH, Sorenson GD, Robinson AG, Zimmerman EA (1977): Isolation and characterization of a hormone-producing cell line from human small cell anaplastic carcinoma of the lung. J Natl Cancer Inst 58:511-8.
5. Fisher ER, Paulson JD (1978): A new in vitro cell line established from human large cell variant of oat cell lung cancer. Cancer Res 38:3830-3835.
6. Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Gate CG, Maurer LH (1980): Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45:906-18.
7. Barnes D, Sato G (1980): Serum-free cell culture. Cell 22:649-655.
8. Barnes DW, Sirbasku A, Sato GH (1984): "Methods for Serum-Free Culture of Epithelial and Fibroblastic Cells." New York: Alan Liss.
9. Simms E, Gazdar AF, Abrams PG, Minna JD (1980): Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor supplemented medium. Cancer Res 40:4356-4363.
10. Carney DN, Bunn PA, Gazdar AF, Pagan JF, Minna JD (1981): Selective growth in serum-free hormone supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sei USA 78:3185-3189.
11. Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC (1990): Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J Natl Cancer Inst 82:117-124.
12. Oie HK, Brower M, Carney DN (1984): Growth factor requirements for in vitro growth of endocrine and nonendocrine lung cancers in serum-free defined media. In Becker KL, Gazdar AF (eds): "The Endocrine Lung in Health and Disease." Philadelphia: W.B. Saunders Co., pp 469-475.
13. CuttittaF.Levitt ML, KasprzykPG.NakanishiY, Reeve J, Walsh J (1987): Growth of human cancer cell lines in unsupplemented basal media as a means of identifying autocrine growth factors. Proc Annu Meet Am Assoc Cancer Res 28:27-0.
14. Cuttitta F, Kasprzyk PG, Treston AM, Avis I, Jensen S, Levitt M, Siegfried J, Mobley C, Mulshine JL (1990): Autocrine growth factors that regulate the proliferation of pulmonary malignancies in man. In Thomassen DG, Nettesheim P (eds): "Respiratory Epithelium." New York: Hemisphere Publishing Corp., pp 228-270.
15. Radice P, Matthews MJ, Ihde DC, Gazdar AF, Carney DN, Bunn PA, Cohen MH, Fossieck BE, Makuch RW, Minna JD (1982): The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer 50:2894-2902.
16. Gazdar AF, Carney DN, Nau MM, Minna JD (1985): Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res 45:2924-2930.
17. Carney DN, Gazdar AF, Bepler G, Guccion J, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985): Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923.
18. Carney DN, Mitchell JB, Kinsella TJ (1983): In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res 43:2806-2811.
19. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983): Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196.
20. Johnson BE, Brennan JF, Ihde DC, Gazdar AF (1992): myc family DNA amplification in tumors and tumor cell lines from patients with small cell lung cancer. J Natl Cancer Inst Monogr 13:39-43.
21. Levenson RM, Ihde DC, Matthews MJ, Cohen MH, Gazdar AF, Bunn PA, Minna JD (1981): Small cell carcinoma presenting as an extrapulmonary neoplasm: Sites of origin and response to chemotherapy. J Natl Cancer Inst 67:607-612.
22. Remick SC, Hafez GR, Carbone PP (1987): Extrapulmonary small cell carcinoma: A review of the literature with emphasis on therapy and outcome. Medicine 66: 457-471.
23. Gazdar AF, Kadoyama C, Venzon D, Park J-G, Tsai C-M, Linnoila RI, Mulshine JL, Ihde DC, Giaccone G (1992): The association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr 13: 23-29.
24. Johnson BE, Whang-Peng J, Naylor SL, Zbar B, Brauch H, Lee E, Simmons A, Russell E, Nam MH, Gazdar AF (1989): Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 81:1223-1228.
25. Lai SL, Goldstein LJ, Gottesman MM, Pastan I, Tsai CM, Johnson BE, Mulshine JL, Ihde DC, Kayser K, Gazdar AF (1989): MDR1 gene expression in lung cancer. J Natl Cancer Inst 81:1144-1150.
26. Lieber M, Smith B, Szakal A, Nelson RW, Todaro G (1976): A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Intl J Cancer 17:62-70.
27. Brower M, Carney DN, Oie HK, Gazdar AF, Minna JD (1986): Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46:798-806.
28. Gazdar AF, Oie HK (1986): Cell culture methods for human lung cancer. Cancer Genet Cytogenet 19:5-10.
29. Gazdar AF, Oie HK (1986): Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium [letter to the editor]. Cancer Res 46:6011.
30. Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE, Gazdar AF (1987): Characteristics of cell lines established from human colorectal carcinomas. Cancer Res 47:6710-6718.
31. Gazdar AF, Linnoila RI, Kurita Y, Oie HK, Mulshine JL, Clark JC, Whitsett JA (1990): Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res 5481-5487.
32. O'Reilly MA, Weaver TE, Pilot MT, Sarin VK, Gazdar AF, Whitsett JA (1989): In vitro translation, posttranslational processing and secretion of pulmonary surfactant protein B precursors. Biochim Biophys Acta 1011:140-148.
33. O'Reilly MA, Gazdar AF.MorrisRE, Whitsett JA(1988): Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta 970:194-204.
34. Levitt ML, Gazdar AF, Oie HK, Schuller H, Thatcher SM (1990): Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines. Cancer Res 50:120-128.
35. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL, Schuller HM, Park JG (1988): Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 48:4078-4082.
36. Skov BG, Sorensen JB, Hirsch FR, Larsson LI, Hansen HH (1991): Prognostic impact of histologie demonstration of chromogranin A and neuron specific enolase in pulmonary adenocarcinoma. Ann Oncol 2:355-60.
37. Sorenson JB, Skov BG, Hirsch FR, Larsson LI, Hansen HH (1989): Prognostic impact of neuron specific enoloase and chromogranin in adenocarcinoma of the lung. Proc Am Soc Clin Oncol 8:220-0.
38. Graziano SL, Mazid R, Newman N, Tatum A, Oler A, Mortimer JA, Gullo JL, DiFino SM, Scalzo AJ (1989): The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with nonsmall cell lung cancer. J Clin Oncol 7:1398-1406.
39. Yoakum GH, Korba BE, Lechner JF, Tokiwa T, Gazdar AF, Leeman MS, Anutrup H, Harris CC (1983): High frequency transfection of cytopathology of the hepatitis B virus core antigen in human cells. Science 222:385-89.
40. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GJ, Nieman L, Chrousos G, Pass H, Doppman J (1991): Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J SurgPathol 15:529-53.
41. Lai S-L, Brauch H, Knutsen T, Johnson BE, Nau MN, Mitsudomi T, Tsai C-M, Whang-Peng J, Zbar B, Kaye FJ, Gazdar AF (1995): Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 15:225-232.
42. Stevenson H, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Ghosh B, Walsh T, Woods EL, Oie H, O'Connor T, Mulshine JL (1990): Tumor cell lines established in vitro: An independent prognostic factor for survival in non-small-cell lung cancer. Ann Intern Med 113:764-770.
43. Stevenson HC, Gazdar AF, Linnoila RI, Russell EK, Oie HK, Steinberg SM, Ihde DC (1989): Lack of relationship between in vitro tumor cell growth and prognosis in extensive stage small cell lung cancer. J Clin Oncol 7:923-931.
44. Morgan D, Ruscetti F, Gallo RC (1976): Selective in vitro growth of T lymphocytes from normal bone marrows. Science 193:1007-1008.
45. Carney DN, BunnPA, SchechterGP, Gazdar AF (1980): Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer 26:535-542.
46. Hollsberg P, Hauer DA (1993): Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328:1173-82.
47. PopovicM, SarngadharanMG, Read E, Gallo RC (1984): Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
48. Levy JA, Huffman AD, Kramer SM, Landis JA, Shimabuku JM (1984): Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840-842.
49. Crewdson J (1989): The great AIDS quest. Chicago Tribune 5:1-16, Nov. 19,1989.
50. Mann DL, O'Brien SJ, Gilbert DA, Reid Y, Popovic M, Read CE, Gallo RC, Gazdar AF (1989): Origin of the HIV-susceptible human CD4+ cell line H9. Aids Res Hum Retroviruses 5:253-255.
51. Rubinstein E (1990): The untold story of HUT78. Science 248:1499-1507.
52. La Rocca RV, Park JG, Danesi R, Del Tacca M, Steinberg SM, Gazdar AF (1992): Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines. Oncology 49:209-14.
53. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT (1992): Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52:1114-22.
54. Park JG, Frucht H, LaRocca RV, Bliss DJ, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, Gazdar AF (1990): Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773-2780.
55. Park JG, Kramer BS, Lai SL, Goldstein LJ, Gazdar AF (1990): Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82:193-198.
56. Park JG, Collins JM, Gazdar AF, Allegra CJ, Steinberg SM, Greene RF, Kramer BS (1988): Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst 80:1560-1564.
57. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF (1987): Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res 47:5875-5879.
58. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, La Rocca RV (1990): Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 50:5488-5496.
59. Bird IM, Hanley NA, Word RA, Mathis JM, McCarthy JL, Mason JI, Rainey WE (1993): Human NCI-H295 adrenocortical carcinoma cells: A model for angiotensinII-responsive aldosterone secretion. Endocrinology 133: 1555-61.
60. Rainey WE, Bird IM, Mason JI (1994): The NCI-H295 cell line: A pluripotent model for human adrenocrotical studies. Mol Cell Endocrinol.
61. Bates SE, Shieh CY, Mickley LA, Dichek HL, Gazdar A, Loriaux DL, Fojo AT (1991): Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas. J Clin Endocrinol Metab 73:18-29.
62. Gazdar AF, Oie HK, Kirsch IR, Hollis GF (1986): Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc protooncogene. Blood 67:1542-1549.
63. Hollis GF, Gazdar AF, Bertness V, Kirsch IR (1988): Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Mol Cell Biol 8:124-129.
64. Whang-Peng J, Fréter CE, Knutsen T, Nanfro JJ, Gazdar A (1987): Translocation t(11;22) in esthesioneuroblastoma. Cancer Genet Cytogenet 29:155-157.
65. Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V (1980): Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sei USA 77:3519-23.
66. Oie HK, Gazdar AF, Minna JD, Weir GC, Baylin SB (1983): Clonal analysis of insulin and somatostatin secretion and L-dopa decarboxylase expression by a rat islet cell tumor. Endocrinology 112:1070-1075.
67. Gazdar AF, Minna JD (1986): Cell lines as an investigational tool for the study of biology of small cell lung cancer. Eur J Cancer Clin Oncol 22:909-11.
68. Gazdar AF, Trent JM (1991): Characterization of human cultures. In Master JR (ed): "Human Cancer in Primary Culture." London: Kluwer Academic, pp 3-27.
69. D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, Gazdar A, Minna JD (1992): High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene 7:339-46.
70. Johnson BE, Makuch RW, Simmons AD, Gazdar AF, BurchD, Cashell AW(1988): myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res 48:5163-5166.
71. Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD, Gazdar AF (1991): Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene 6:1353-1362.
72. Whang-Peng J, Kao SC, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD (1982): A specific chromosome defect associated with human small cell lung cancer. Science 215:181-185.
73. Brauch H, Tory K, Kotler F, Gazdar AF, Pettengill OS, Johnson B, Graziano S, Winton T, Buys CH, Sorenson GD, Minna J, Zbar B (1990): Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chrom Cancer 1:240-246.
74. Tsai CM, Ihde DC, Kadoyama C, Venzon D, Gazdar AF (1990): Correlation of in vitro drug sensitivity testing of long-term small cell lung cancer cell lines with response and survival. Eur J Cancer 26:1148-1152.
75. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988): Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589-601.